Rheumatoid Arthritis
Item
diagnosis of ra as defined by the american college of rheumatology (acr) and consistent with revised criteria for ra
boolean
C0003873 (UMLS CUI [1])
Disease-Modifying Antirheumatic Drugs Stable Duration | Medication dose changed
Item
stable disease-modifying drug regimen for 3 months prior to study entry, with no change in drug dosage for at least 3 months prior to study entry
boolean
C0242708 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C1608430 (UMLS CUI [2])
Clinical course of disease Stable Relative
Item
relatively stable disease course for 3 months prior to study entry
boolean
C0449259 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205345 (UMLS CUI [1,3])
Adrenal Cortex Hormones Dose Stable
Item
if treated with corticosteroids, must be on a stable dosage for 3 months prior to study entry
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Prednisone Dose U/day
Item
if taking prednisone, must be on a dosage less than or equal to 10 mg/day or equivalent
boolean
C0032952 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Reside Los Angeles County, CA
Item
resides in greater los angeles area
boolean
C2982691 (UMLS CUI [1,1])
C3829255 (UMLS CUI [1,2])
Rheumatoid Arthritis remission
Item
inactive ra conditions defined as "in remission"
boolean
C0003873 (UMLS CUI [1,1])
C0544452 (UMLS CUI [1,2])
Flare Severe Frequent | Disease-Modifying Antirheumatic Drugs Therapy change Patient need for
Item
experiencing frequent, severe disease flares that require changes in primary disease-modifying regimen
boolean
C1517205 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332183 (UMLS CUI [1,3])
C0242708 (UMLS CUI [2,1])
C3665894 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
Medical condition Serious | Diabetes Mellitus | Congestive heart failure | Kidney Failure Requirement Therapeutic procedure Specific | Malignant Neoplasms Cure of disease | Endocrine System Diseases Uncontrolled | Thyroid Diseases | Chronic infectious disease Uncontrolled | Medical condition Uncontrolled Interferes with Clinical Trial
Item
serious medical conditions, including: diabetes, congestive heart failure, renal failure requiring specific treatment, cancer (unless cured for period of 5 years or more), unregulated endocrine disorders (including thyroid disorders), chronic uncontrolled infection, or any uncontrolled medical condition that may interfere with the study
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0011849 (UMLS CUI [2])
C0018802 (UMLS CUI [3])
C0035078 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C0087111 (UMLS CUI [4,3])
C0205369 (UMLS CUI [4,4])
C0006826 (UMLS CUI [5,1])
C0679252 (UMLS CUI [5,2])
C0014130 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
C0040128 (UMLS CUI [7])
C0151317 (UMLS CUI [8,1])
C0205318 (UMLS CUI [8,2])
C3843040 (UMLS CUI [9,1])
C0205318 (UMLS CUI [9,2])
C0521102 (UMLS CUI [9,3])
C0008976 (UMLS CUI [9,4])
Therapeutic procedure Rheumatoid Arthritis | Analgesics | Opioids | Acetaminophen | Anti-Inflammatory Agents, Non-Steroidal | Tramadol | Ultram | Tylenol with Codeine | Propoxyphene | Darvocet | Wygesic
Item
use of analgesics (e.g., opioids) other than acetaminophen or non-steroidal anti-inflammatory agents prescribed for ra treatment, tramadol (ultram) or tylenol with codeine on an as-needed basis, or propoxyphen (darvocet, wygesic)
boolean
C0087111 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C0002771 (UMLS CUI [2])
C0242402 (UMLS CUI [3])
C0000970 (UMLS CUI [4])
C0003211 (UMLS CUI [5])
C0040610 (UMLS CUI [6])
C0724054 (UMLS CUI [7])
C0724034 (UMLS CUI [8])
C0033493 (UMLS CUI [9])
C1514497 (UMLS CUI [10])
C0724411 (UMLS CUI [11])
Oxycodone | Percocet | Hydrocodone | Vicodin | Morphine | Hydromorphone | Dilaudid
Item
use of oxycodone (percocet), hydrocodone (vicodin), morphine, or hydromorphone (dilaudid)
boolean
C0030049 (UMLS CUI [1])
C0086787 (UMLS CUI [2])
C0020264 (UMLS CUI [3])
C0483514 (UMLS CUI [4])
C0026549 (UMLS CUI [5])
C0012306 (UMLS CUI [6])
C0728755 (UMLS CUI [7])
Methotrexate High dose
Item
use of high levels of methotrexate (greater than 7.5 mg)
boolean
C0025677 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Mechlorethamine | Cyclosporine | Monoclonal antibodies, antineoplastic | Cyclophosphamide
Item
use of nitrogen mustard, cyclosporine, monoclonal antibodies, or cyclophosphamide within the 6 months prior to study entry
boolean
C0025033 (UMLS CUI [1])
C0010592 (UMLS CUI [2])
C3542957 (UMLS CUI [3])
C0010583 (UMLS CUI [4])
Mental disorders Serious | Bipolar Disorder | Psychotic Disorders | Organic brain syndrome
Item
serious psychiatric conditions, such as bipolar disorder, psychotic disorders, or organic brain syndromes
boolean
C0004936 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0005586 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
C0029221 (UMLS CUI [4])
At risk for suicide
Item
at risk for suicide
boolean
C0563664 (UMLS CUI [1])
Cane user | Dependence on walking stick | Self-Help Devices Dependent
Item
dependent on canes, walkers, or other assistive devices
boolean
C0920240 (UMLS CUI [1])
C0524378 (UMLS CUI [2])
C0036605 (UMLS CUI [3,1])
C0851827 (UMLS CUI [3,2])
Protocol Compliance Unable | Protocol Compliance Unwilling
Item
unable to commit to study schedule/itinerary or unwilling to be assigned to any of the 3 treatment groups
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])